Breaking News Instant updates and real-time market news.

KSU

Kansas City Southern

$122.85

4.81 (4.07%)

08:58
04/18/19
04/18
08:58
04/18/19
08:58

Kansas City Southern price target raised to $130 from $122 at BMO Capital

BMO Capital analyst Fadi Chamoun raised his price target on Kansas City Southern to $130 and kept his Outperform rating after its Q1 results. The analyst cites the company's revenue beat and better visibility into its "improving operating efficiency" within a "rising volume environment". Chamoun also believes that Kansas City Southern's implementation of precision scheduled railroading should support its "robust" earnings growth in the coming years.

  • 08

    May

  • 17

    May

  • 13

    Nov

KSU Kansas City Southern
$122.85

4.81 (4.07%)

02/20/19
DBAB
02/20/19
NO CHANGE
DBAB
Buy
Deutsche Bank places 'Catalyst Call' buy on Kansas City Southern
Deutsche Bank analyst Amit Mehrotra placed a "Catalyst Call" buy on Kansas City Southern as a short-term investment idea. Following a meeting with the company's CFO, the analyst believes market participants are underappreciating progress of Kansas City's new precision scheduled railroading initiatives. The progress will become more evident this week at industry conferences, in results over next six months, and an analyst day likely later this year, Mehrotra tells investors in a research note. He keeps a Buy rating on Kansas City Southern.
02/22/19
LOOP
02/22/19
NO CHANGE
Target $132
LOOP
Buy
Kansas City Southern offers low valuation, easy comps, says Loop Capital
Loop Capital analyst Rick Paterson kept his Buy rating and $132 price target on Kansas City Southern, saying the company is the "next man up" to make a "splash" in implementing Precision Scheduled Railroading. The analyst also sees greater investor interest in the name and the lowest valuation in the rail sector, adding that Kansas City Southern's 2019 comps are also relatively easy because of the January 2018 closure of the Luminant Monticello Texas utility plant which drove the total volumes for last year to grow by "only" 1.6%.
03/06/19
SBSH
03/06/19
NO CHANGE
Target $130
SBSH
Buy
Kansas City Southern target raised to $130 on PSR opportunity at Citi
Citi analyst Christian Wetherbee says his deep dive into Kansas City Southern's Precision Scheduled Railroading opportunity suggests "solid" upside potential to its operating ratio and earnings. As the company begins to release incremental information into the market over the next several weeks and months, he potential for improvement can be a catalyst for shares, Wetherbee tells investors in a research note. The analyst's base case calls for a "multi-year runway" to $157 per share, or 42% upside, while his bull case yields 65% upside to $183 per share in the long-term. He raised his price target for Kansas City Southern to $130 and keeps a Buy rating on the name.
03/15/19
DBAB
03/15/19
NO CHANGE
DBAB
Deutsche closes short-term ideas on XPO, Kansas City Southern
Deutsche Bank analyst Amit Mehrotra closes his short-term ideas on both XPO Logistics (XPO) and Kansas City Southern (KSU). On XPO, the analyst says the "quick recovery" in the shares he expected from management's buyback efforts has not materialized. However, his long-term fundamental rating remains Buy on the stock. On Kansas City Southern, Mehrotra notes the shares are now the best performing rail stock year-to-date. His long-term fundamental rating remains Buy on the shares.

TODAY'S FREE FLY STORIES

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Retail Sales less autos to be reported at 08:30 »

November Retail Sales…

EA

Electronic Arts

$105.08

1.9 (1.84%)

, ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

EA

Electronic Arts

$105.08

1.9 (1.84%)

ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

GME

GameStop

$5.58

0.05 (0.90%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$125.33

2.95 (2.41%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Retail Sales to be reported at 08:30 »

November Retail Sales…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Business Inventories to be reported at 10:00 »

October Business…

TTWO

Take-Two

$125.33

2.95 (2.41%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Take-Two management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

HY

Hyster-Yale Materials

$64.70

1.14 (1.79%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Hyster-Yale Materials management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 26

    Feb

OGI

Organigram

$2.57

(0.00%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Organigram management to meet with Cantor Fitzgerald »

Analyst Pablo Zuanic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
BTIG biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Breaking General news story  »

Week of 12/13…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
JPMorgan oil services/equip analyst to hold an analyst/industry conference call »

Oil Services &…

RPT

Ramco-Gershenson

$14.52

-0.2 (-1.36%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Ramco-Gershenson management to meet with KeyBanc »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 20

    Feb

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
JPMorgan media analyst to hold an analyst/industry conference call »

Media Analyst Quadrani…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
UBS services analysts to hold an analyst/industry conference call »

Services Analysts Geiger…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Breaking General news story  »

Week of 12/13…

RYAAY

Ryanair

$84.33

-0.15 (-0.18%)

04:54
12/13/19
12/13
04:54
12/13/19
04:54
Upgrade
Ryanair rating change  »

Ryanair upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAGY

IAG

$0.00

(0.00%)

04:54
12/13/19
12/13
04:54
12/13/19
04:54
Upgrade
IAG rating change  »

IAG upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:40
12/13/19
12/13
04:40
12/13/19
04:40
General news
FX Action: The yen has traded lower »

FX Action: The yen has…

03:55
12/13/19
12/13
03:55
12/13/19
03:55
General news
FX Action: USD-CAD dropped to a near six-week low »

FX Action: USD-CAD…

01:50
12/13/19
12/13
01:50
12/13/19
01:50
General news
Asian Market Update: »

Asian Market Update:…

SPT

Sprout Social

20:34
12/12/19
12/12
20:34
12/12/19
20:34
Syndicate
Sprout Social 8.824M share IPO priced at $17.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

SCHW

Charles Schwab

$51.08

1.48 (2.98%)

20:16
12/12/19
12/12
20:16
12/12/19
20:16
Upgrade
Charles Schwab rating change at Keefe Bruyette »

Charles Schwab upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$84.00

-2.97 (-3.41%)

20:08
12/12/19
12/12
20:08
12/12/19
20:08
Upgrade
Bluebird Bio rating change at Oppenheimer »

Bluebird Bio upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$6.73

-0.97 (-12.60%)

20:07
12/12/19
12/12
20:07
12/12/19
20:07
Syndicate
Aquestive Therapeutics 7M share Secondary priced at $5.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BY

Byline Bancorp

$18.95

0.54 (2.93%)

19:56
12/12/19
12/12
19:56
12/12/19
19:56
Hot Stocks
Byline Bancorp initiates 3c per share cash dividend »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

NXGN

NextGen Healthcare

$16.83

-1.28 (-7.07%)

19:08
12/12/19
12/12
19:08
12/12/19
19:08
Downgrade
NextGen Healthcare rating change at Cantor Fitzgerald »

NextGen Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.